Conference Programme
Maximising Returns from Life Science Innovation
10 December 2026
Maximising Returns from Life Science Innovation
Plenary Programme
Taking place again in the Guy Whittle Auditorium, the 2025 Keynote Programme at Genesis will explore the exciting potential offered by innovation in life sciences to address global unmet medical needs, investment returns and new treatment development challenges. The sessions will discuss how the barriers to progress can be defeated through creative thinking in R&D, collaboration, investment and patient access to translate the golden triangle of ‘technology-people-money’ into value creation for all stakeholders.
Provisional Agenda (Subject to Change)
Registration
Welcome from One Nucleus
Tony Jones, CEO, One Nucleus
SESSION 1
Plenary Address: Winners & Losers 2026
Mike Ward, Global Head of Life Sciences Thought Leadership, Clarivate
Plenary Panel: Has Life Science Investment Returned with New Expectations?
Coffee Break
SESSION 2
Keynote Panel 1: What is the Next Scientific Frontier in Life Science Innovation?
Keynote Panel 2: Human vs Machine: Who are the future innovators, investors and regulators?
Lunch Break
SESSION 3
Keynote Panel 3: Look East, Look West or Look Both Ways for Bio-Deals 2027?
Fireside Chat – Case Study Deal
Fireside Chat – Case Study Deal
Tea Break
SESSION 4
Fireside Chat – The Patient Experience
Keynote Panel 4 – Is the UK a Rare Commodity?
Closing Remarks
Tony Jones
Drinks Reception
Close
Programme is subject to change